These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 210874

  • 1. Differences in dihydroergotamine antagonism of glucose release by catecholamines, glucagon and adenosine 3',5'-monophosphate in rabbit liver slices.
    Chan PS, Ellis S, Mühlbachová E.
    Br J Pharmacol; 1978 Aug; 63(4):593-7. PubMed ID: 210874
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quantitative studies of glucose release from rabbit liver slices induced by catecholamines and their antagonism by propranolol and phentolamine.
    Mühlbachová E, Chan PS, Ellis S.
    J Pharmacol Exp Ther; 1972 Sep; 182(3):370-7. PubMed ID: 5055400
    [No Abstract] [Full Text] [Related]

  • 6. Responsiveness to glucagon by isolated rat hepatocytes controlled by the redox state of the cytosolic nicotinamide--adenine dinucleotide couple acting on adenosine 3':5'-cyclic monophosphate phosphodiesterase.
    Clark MG, Jarrett IG.
    Biochem J; 1978 Dec 15; 176(3):805-16. PubMed ID: 218554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cyclic adenosine 3',5'-monophosphate concentration in rabbit parotid slices following stimulation by secretagotues.
    Monnard P, Schorderet M.
    Eur J Pharmacol; 1973 Sep 15; 23(3):306-10. PubMed ID: 4355730
    [No Abstract] [Full Text] [Related]

  • 10. Contribution by the glycogen pool and adenosine 3',5'-monophosphate release to the evanescent effect of glucagon on hepatic glucose production in vitro.
    Komjati M, Breitenecker F, Bratusch-Marrain P, Gampe J, Vierhapper H, Troch I, Waldhäusl W.
    Endocrinology; 1985 Mar 15; 116(3):978-86. PubMed ID: 2578952
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.
    González-Hernández A, Lozano-Cuenca J, Marichal-Cancino BA, MaassenVanDenBrink A, Villalón CM.
    J Headache Pain; 2018 May 25; 19(1):40. PubMed ID: 29802544
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.
    Gray DW, Marshall I.
    Br J Pharmacol; 1992 Nov 25; 107(3):684-90. PubMed ID: 1335334
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of cytosolic-[Ca2+] oscillations in hepatocytes results from cross-talk among second messengers. The synergism between the alpha 1-adrenergic response, glucagon and cyclic AMP, and their antagonism by insulin and diacylglycerol manifest themselves in the control of the cytosolic-[Ca2+] oscillations.
    Somogyi R, Zhao M, Stucki JW.
    Biochem J; 1992 Sep 15; 286 ( Pt 3)(Pt 3):869-77. PubMed ID: 1329720
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The activation of Na+-dependent efflux of Ca2+ from liver mitochondria by glucagon and beta-adrenergic agonists.
    Goldstone TP, Duddridge RJ, Crompton M.
    Biochem J; 1983 Feb 15; 210(2):463-72. PubMed ID: 6134523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.